What does the evidence show about Beta-glucans (yeast / mushroom)'s effects?

Read Off Label rates the evidence for Beta-glucans (yeast / mushroom) as Weak-Moderate and the benefit magnitude as low-med, producing an overall grade of B- (6.2/10). Trained immunity concept (Netea) provides better mechanism framing than older 'immune booster' claims.

What safety findings are reported for Beta-glucans (yeast / mushroom)?

Beta-glucans (yeast / mushroom) has a low risk profile in the database. Low (generally well-tolerated; theoretical hypoglycemia) Legal status: OTC.

What doses or routes are reported for Beta-glucans (yeast / mushroom)?

250-500 mg/day standardized yeast β-glucan; mushroom products vary This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.

Rankings / Immune & Inflammation

Beta-glucans (yeast / mushroom)

Immune & Inflammation · Polysaccharide PAMP mimetic

Tier B-

Reviewed by Read Off Label · Last reviewed Jun 8, 2026 · How we grade

otc

6.2 / 10

Tier B-

Ev 4.5 Bn 3.5 Sf 9

Bottom line

Read Off Label grades Beta-glucans (yeast / mushroom) as B- (6.2/10) based on weak-moderate evidence, low-med benefit magnitude, and a low-risk safety profile.

Trained immunity concept (Netea) provides better mechanism framing than older 'immune booster' claims.

Studied, labeled, or reported-use context: 250-500 mg/day standardized yeast β-glucan; mushroom products vary — OTC; not individualized guidance.

What the evidence says

Trained immunity concept (Netea) provides better mechanism framing than older 'immune booster' claims. Auinger 2013 trials with Wellmune (yeast β-glucan 1,3/1,6) showed URI reduction. Source, purity, and molecular weight matter — mushroom products highly variable.

Mechanism

(1,3)/(1,6)-β-glucans from baker's yeast or medicinal mushrooms (maitake D-fraction, shiitake lentinan, reishi); bind Dectin-1 and CR3 on innate immune cells; trained immunity induction

Studied, labeled, or reported dose & route

250-500 mg/day standardized yeast β-glucan; mushroom products vary

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Beta-glucans (yeast / mushroom)'s effects?: Read Off Label rates the evidence for Beta-glucans (yeast / mushroom) as Weak-Moderate and the benefit magnitude as low-med, producing an overall grade of B- (6.2/10). Trained immunity concept (Netea) provides better mechanism framing than older 'immune booster' claims.
What safety findings are reported for Beta-glucans (yeast / mushroom)?: Beta-glucans (yeast / mushroom) has a low risk profile in the database. Low (generally well-tolerated; theoretical hypoglycemia) Legal status: OTC.
What doses or routes are reported for Beta-glucans (yeast / mushroom)?: 250-500 mg/day standardized yeast β-glucan; mushroom products vary This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Beta-glucans (yeast / mushroom) work?: (1,3)/(1,6)-β-glucans from baker's yeast or medicinal mushrooms (maitake D-fraction, shiitake lentinan, reishi); bind Dectin-1 and CR3 on innate immune cells; trained immunity induction

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.